Log In
Print this Print this

Nuplazid, pimavanserin (formerly ACP-103)

Also known as: pimavanserin tartrate

  Manage Alerts
Collapse Summary General Information
Company Acadia Pharmaceuticals Inc.
DescriptionSmall molecule serotonin (5-HT2A) receptor inverse agonist
Molecular Target Serotonin (5-HT2A) receptor
Mechanism of ActionSerotonin (5-HT2A) receptor inverse agonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today